Neupogen (Filgrastim) Drug Interactions: 1 Major, 6 Moderate
Neupogen (Filgrastim) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Neupogen. Always confirm against the full prescribing information.
100 interactions
Bleomycin
The risk or severity of pulmonary toxicity can be increased when Filgrastim is combined with Bleomycin.
Level 1 evidence
Abacavir
Abacavir may increase the hepatotoxic activities of Filgrastim.
Level 2 evidence
Abatacept
Filgrastim may increase the hepatotoxic activities of Abatacept.
Level 2 evidence
Abemaciclib
Filgrastim may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Filgrastim.
Level 2 evidence
Acamprosate
Filgrastim may increase the hepatotoxic activities of Acamprosate.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Filgrastim.
Level 2 evidence
Acebutolol
Filgrastim may increase the hepatotoxic activities of Acebutolol.
Level 2 evidence
Aceclofenac
Filgrastim may increase the hepatotoxic activities of Aceclofenac.
Level 2 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Filgrastim.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Filgrastim.
Level 2 evidence
Acetylsalicylic acid
Filgrastim may increase the hepatotoxic activities of Acetylsalicylic acid.
Neupogen (Filgrastim) has 491 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Neupogen (Filgrastim) has 1 major, 6 moderate, and 484 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Neupogen. Always confirm against the full prescribing information.